EBITDA

As Organigram preps its Q3 results, all eyes are on its German expansion and its ability to defend its top spot in the competitive Canadian market.

MagIron unveils a multi-billion dollar plan to end U.S. reliance on imported pig iron, a critical step for national security and steel decarbonization.

As corporate buyers reshape healthcare, a new guide urges independent doctors to control their destiny by understanding their practice's true value and exit options.

A major property sale in Pärnu falls apart, leaving Nordic Fibreboard with a strategic void. We explore the risks of 'conditions precedent' and what this means for the company.

The creation of an offshore energy titan moves one step closer with US antitrust approval, but a deeper probe in Europe will decide its ultimate fate.

Abu Dhabi's healthcare giant reports a 20% profit jump, fueled by aggressive European expansion. Its strategy reveals a blueprint for a new kind of global power.

While global industrial markets waver, refractory leader RHI Magnesita proves strategic self-help can deliver powerful growth. Here's how they're doing it.

Amid production stoppages from extreme weather, nuclear operator Orano reveals a complex financial picture and a bold strategy for US expansion and diversification.

PHINIA posts strong Q2 sales and announces a key acquisition to bolster its supply chain, signaling a dual focus on current performance and long-term resilience.

SunCoke Energy's stellar Q2 results reveal a masterstroke in strategy, with its Phoenix acquisition driving record growth and diversifying the firm's future.

Amid record revenues, Martin Marietta's blockbuster deal for Lhoist North America signals a bold pivot beyond construction into industrial minerals.

The science firm sees a return to growth, driven by its Materials unit. A strategic review of its Performance & Care segment signals a major shift.

European gaming giant FDJ UNITED faces a revenue dip from new taxes and extreme weather, forcing a strategic pivot. Can cost cuts and innovation secure its future?

In a story of strategic foresight, European mall giant Klépierre's stellar results reveal a thriving physical retail market, fueled by a Southern European renaissance.

With a history of beating expectations and a new acquisition in tow, all eyes are on Calian's Q3 results to see if its mission-critical strategy can sustain momentum.

Facing a harsh new Nasdaq rule, HCTI used legacy M&A deals to boost its market value, tying its survival to a strategic pivot toward AI and global expansion.

Solid Q2 earnings are just the start. Photocure is moving beyond its core imaging tech with key acquisitions and AI partnerships, building a full-spectrum platform.

Despite sales and profit dips from market weakness and Mideast conflict, the chemical giant reaffirms its 2026 outlook, betting on a second-half recovery.

GCC's stellar Q2 2026 results reveal a strategy of aggressive expansion and fiscal discipline, with record sales and a rare negative net leverage.

While broader healthcare dealmaking slows, a perfect storm of fresh private equity capital and new regulations is making dermatology a hotbed of investment.